ECSP056015A - ANTIBODIES AGAINST THE RECEIVER OF HUMAN IL-21 AND USES OF THE SAME - Google Patents

ANTIBODIES AGAINST THE RECEIVER OF HUMAN IL-21 AND USES OF THE SAME

Info

Publication number
ECSP056015A
ECSP056015A ECSP056015A ECSP056015A EC SP056015 A ECSP056015 A EC SP056015A EC SP056015 A ECSP056015 A EC SP056015A EC SP056015 A ECSP056015 A EC SP056015A
Authority
EC
Ecuador
Prior art keywords
human
receiver
same
antibodies against
antibodies
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Viia Valge-Archer
Deborah A Young
Matthew J Whitters
Mary Collins
Andrew James Williams
Joanne Witek
Original Assignee
Wyeth Corp
Cambridge Antibody Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp, Cambridge Antibody Tech filed Critical Wyeth Corp
Priority to ECSP056015 priority Critical patent/ECSP056015A/en
Publication of ECSP056015A publication Critical patent/ECSP056015A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Anticuerpos humanos y fragmentos de unión al antígeno de los mismos que se unen específicamente al receptor humano de la interleuquina -21 (IL-21R). Los anticuerpos pueden actuar como antagonistas de la actividad de IL21R modulando por lo tanto las respuestas inmunes en general y aquellas en las que interviene IL-21R en particular. Las composiciones descritas y los métodos se pueden utilizar por ejemplo, en el diagnóstico, tratamiento o prevención de trastornos inflamatorios, enfermedades autoinmunes, alergias, rechazo a trasplantes, cáncer y otros del sistema inmunológico.Human antibodies and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). Antibodies can act as antagonists of IL21R activity thereby modulating immune responses in general and those in which IL-21R intervenes in particular. The described compositions and methods can be used for example, in the diagnosis, treatment or prevention of inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer and others of the immune system.

ECSP056015 2005-09-13 2005-09-13 ANTIBODIES AGAINST THE RECEIVER OF HUMAN IL-21 AND USES OF THE SAME ECSP056015A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP056015 ECSP056015A (en) 2005-09-13 2005-09-13 ANTIBODIES AGAINST THE RECEIVER OF HUMAN IL-21 AND USES OF THE SAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP056015 ECSP056015A (en) 2005-09-13 2005-09-13 ANTIBODIES AGAINST THE RECEIVER OF HUMAN IL-21 AND USES OF THE SAME

Publications (1)

Publication Number Publication Date
ECSP056015A true ECSP056015A (en) 2006-09-18

Family

ID=40203017

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP056015 ECSP056015A (en) 2005-09-13 2005-09-13 ANTIBODIES AGAINST THE RECEIVER OF HUMAN IL-21 AND USES OF THE SAME

Country Status (1)

Country Link
EC (1) ECSP056015A (en)

Similar Documents

Publication Publication Date Title
AR043616A1 (en) ANTIBODIES AGAINST HUMAN RECEIVER IL-21 AND USES OF THE SAME
ECSP088751A (en) ANTIBODIES AGAINST HUMAN IL-22 AND USES FOR THE SAME
FR22C1052I1 (en) HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN THE TREATMENT OF TUMOURS, TRANSPLANTATION AND AUTOIMMUNE DISEASES
SA522432518B1 (en) Bicyclic Heteroaryl Compounds and Uses Thereof
CR10231A (en) METHODS FOR THE USE OF ANTIBODIES AGAINST HUMAN IL-22
MX2020006715A (en) SPECIFIC ANTIBODIES TO CD3-DELTA/EPSILON HETERODIMER.
PH12017500402A1 (en) Anti-glucagon antibodies and uses thereof
ECSP12012211A (en) COMPOSITIONS OF ANTI-FACTOR ANTI-FACTOR OF NERVOUS GROWTH (NGF)
UA104663C2 (en) CD127-BINDING ANTIBODY $CD127-BINDING ANTIBODY
CR20110118A (en) TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
MX376808B (en) ANTI-B7-H5 ANTIBODIES AND THEIR USES.
JO3246B1 (en) High affinity human antibodies to human protease-activated receptor-2
AR077333A1 (en) HIGH AFFINITY HUMAN ANTIBODIES FOR HUMAN ANGIOPOYETIN -2
BR112016013109A2 (en) anti-siglec-8 antibodies and methods of use
PH12015500114B1 (en) HUMAN ANTIBODIES TO GFRa3 AND METHODS OF USE THEREOF
PH12019500643A1 (en) Antibodies that bind interleukin-2 and uses thereof
CL2015002030A1 (en) Substituted bicyclic dihydropyrimidinomas and their use as inhibitors of neutrophilic elastase activity
AR072136A1 (en) TREATMENT METHODS USING IN-TERLEUQUINE RECEIVER UNION PROTEINS 21
CY1121933T1 (en) SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR USE AS INHIBITORS OF NEUTROPHILIC ELASTASIS ACTIVITY
MX378749B (en) AGENTS FOR INFLUENZA NEUTRALIZATION.
EA201391440A1 (en) DERIVATIVES OF PYRAZOLOPYRIMIDINE
MY149448A (en) Interleukin-21 receptor binding proteins
GT201300058A (en) ANTI-VEGFR-3 ANTIBODY COMPOSITIONS
ECSP056015A (en) ANTIBODIES AGAINST THE RECEIVER OF HUMAN IL-21 AND USES OF THE SAME
EA201990824A1 (en) ANTIBODIES THAT CONTACT INTERLEUKIN-2 AND THEIR APPLICATION